Health Problems of Civilization
eISSN: 2354-0265
ISSN: 2353-6942
Health Problems of Civilization Physical activity: diseases and issues recognized by the WHO
Bieżący numer Archiwum Online first O czasopiśmie Rada naukowa Recenzenci Bazy indeksacyjne Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
Poleć ten artykuł:
Udostępnij:
Artykuł przeglądowy

UNUSUAL SYMPTOMS AND SERIOUS CONSEQUENCES: URINARY TRACT INFECTIONS IN OLDER ADULTS

Julia Dulębska
1
,
Anna Dziuba
1
,
Monika Wawszczak-Kasza
1

  1. Institute of Medical Sciences, Jan Kochanowski University of Kielce, Kielce, Poland
Health Prob Civil.
Data publikacji online: 2025/12/15
Plik artykułu:
- Dulębska et al.pdf  [0.52 MB]
Pobierz cytowanie
 
Metryki PlumX:
 
1. Zhou Y, Zhou Z, Zheng L, Gong Z, Li Y, Jin Y, et al. Urinary tract infections caused by uropathogenic Escherichia coli: mechanisms of infection and treatment options. Int J Mol Sci. 2023; 24(13): 10537. https://doi.org/10.3390/ijms241310537
2. Rowe TA, Juthani-Mehta M. Diagnosis and management of urinary tract infection in older adults. Infect Dis Clin North Am. 2014; 28(1): 75-89. https://doi.org/10.1016/j.idc.2013.10.004
3. Sung WH, Liu CY, Yang CY, Chen CH, Tsao YT, Shen CF, et al. Urinalysis using a diaper-based testing device. Biosensors (Basel). 2020; 10(8): 94. https://doi.org/10.3390/bios10080094
4. Medina-Polo J, Naber KG, Bjerklund Johansen TE. Healthcare-associated urinary tract infections in urology. GMS Infect Dis. 2021; 9: Doc05. https://doi.org/10.3205/id000074
5. Ostrowska K, Strzelczyk A, Różalski A, Stączek P. [Bacterial biofilm as a cause of urinary tract infection – pathogens, methods of prevention and eradication]. Postepy Hig Med Dosw (Online). 2013; 67: 1027-1033 (in Polish). https://doi.org/10.5604/17322693.1073567
6. Mancuso G, Midiri A, Gerace E, Marra M, Zummo S, Biondo C. Urinary tract infections: the current scenario and future prospects. Pathogens. 2023; 12(4): 623. https://doi.org/10.3390/pathogens12040623
7. Timm MR, Russell SK, Hultgren SJ. Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics. Nat Rev Microbiol. 2025; 23(2): 72-86. https://doi.org/10.1038/s41579-024-01092-4
8. Neumeier V, Stangl FP, Borer J, Anderson CE, Birkhäuser V, Chemych O, et al. Indwelling catheter vs intermittent catheterization: is there a difference in UTI susceptibility?. BMC Infect Dis. 2023; 23(1): 507. https://doi.org/10.1186/s12879-023-08475-7
9. Klein RD, Hultgren SJ. Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies. Nat Rev Microbiol. 2020; 18(4): 211-226. https://doi.org/10.1038/s41579-020-0324-0
10. Mody L, Juthani-Mehta M. Urinary tract infections in older women: a clinical review. JAMA. 2014; 311(8): 844-854. https://doi.org/10.1001/jama.2014.303
11. Sarowska J, Futoma-Koloch B, Jama-Kmiecik A, Frej-Madrzak M, Ksiazczyk M, Bugla-Ploskonska G, et al. Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: recent reports. Gut Pathog. 2019; 11: 10. https://doi.org/10.1186/s13099-019-0290-0
12. Dziuba A, Dzierżak S, Sodo A, Wawszczak-Kasza M, Zegadło K, Białek J, et al. Comparative study of virulence potential, phylogenetic origin, CRISPR-Cas regions and drug resistance of Escherichia coli isolates from urine and other clinical materials. Front Microbiol. 2023; 14: 1289683. https://doi.org/10.3389/fmicb.2023.1289683
13. Rather MA, Gupta K, Mandal M. Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies. Braz J Microbiol. 2021; 52(4): 1701-1718. https://doi.org/10.1007/s42770-021-00624-x
14. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015; 13(5): 269-284. https://doi.org/10.1038/nrmicro3432
15. Hannan TJ, Totsika M, Mansfield KJ, Moore KH, Schembri MA, Hultgren SJ. Host–pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev. 2012; 36(3): 616-648. https://doi.org/10.1111/j.1574-6976.2012.00339.x
16. World Health Organization. Ageing and health [Internet]. Geneva: WHO; 2025 (access 2025 October). Available from: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health
17. Tullus K, Shaikh N. Urinary tract infections in children. Lancet. 2020; 395(10237): 1659-1668. https://doi.org/10.1016/S0140-6736(20)30676-0
18. Al Lawati H, Blair BM, Larnard J. Urinary tract infections: core curriculum 2024. Am J Kidney Dis. 2024; 83(1): 90-100. https://doi.org/10.1053/j.ajkd.2023.08.009
19. Zeng G, Zhu W, Lam W, Bayramgil A. Treatment of urinary tract infections in the old and fragile. World J Urol. 2020; 38(11): 2709-2720. https://doi.org/10.1007/s00345-020-03159-2
20. Bausch K, Stangl FP, Prieto J, Bonkat G, Kranz J. Urinary infection management in frail or comorbid older individuals. Eur Urol Focus. 2024; 10(5): 731-733. https://doi.org/10.1016/j.euf.2024.08.007
21. Dutta C, Pasha K, Paul S, Abbas MS, Nassar ST, Tasha T, et al. Urinary tract infection induced delirium in elderly patients: a systematic review. Cureus. 2022; 14(12): e32321. https://doi.org/10.7759/cureus.32321
22. Foxman B, Bangura M, Kamdar N, Morgan DM. Epidemiology of urinary tract infection among community-living seniors aged 50 plus: population estimates and risk factors. Ann Epidemiol. 2025; 104: 21-27. https://doi.org/10.1016/j.annepidem.2025.02.010
23. Mayne S, Bowden A, Sundvall PD, Gunnarsson R. The scientific evidence for a potential link between confusion and urinary tract infection in the elderly is still confusing: a systematic literature review. BMC Geriatr. 2019; 19(1): 32. https://doi.org/10.1186/s12877-019-1049-7
24. Singh H, Giardina TD, Meyer AN, Forjuoh SN, Reis MD, Thomas EJ. Types and origins of diagnostic errors in primary care settings. JAMA Intern Med. 2013; 173(6): 418-425. https://doi.org/10.1001/jamainternmed.2013.2777
25. Caterino JM, Leininger R, Kline DM, Southerland LT, Khaliqdina S, Baugh SK, et al. Accuracy of current diagnostic criteria for acute bacterial infection in older adults in the emergency department. J Am Geriatr Soc. 2017; 65(8): 1802-1809. https://doi.org/10.1111/jgs.14912
26. Long B, Koyfman A. The emergency department diagnosis and management of urinary tract infection. Emerg Med Clin North Am. 2018; 36(4): 685-710. https://doi.org/10.1016/j.emc.2018.06.003
27. Mirsaidov N, Wagenlehner FM. [Urinary tract infections in the elderly]. Urologe. 2016; 55(4): 494-498 (in German). https://doi.org/10.1007/s00120-016-0048-y
28. Lila ASA, Rajab AAH, Abdallah MH, Rizvi SMD, Moin A, Khafagy ES, et al. Biofilm lifestyle in recurrent urinary tract infections. Life (Basel). 2023; 13(1): 148. https://doi.org/10.3390/life13010148
29. Swatesutipun V. Can recurrent UTIs in women be cured?. Continence Rep. 2023; 5: 100021. https://doi.org/10.1016/j.contre.2023.100021
30. Toczek-Wasiak A, Salata B, Dzierżanowski T. Urinary tract infections in palliative care. Med Paliat/Palliative Med. 2022; 14(1): 18-27. https://doi.org/10.5114/pm.2022.118346
31. Kim SJ, Ryu JH, Kim YB, Yang SO. Management of Candida urinary tract infection in the elderly. Urogenit Tract Infect. 2019; 14(2): 33-41. https://doi.org/10.14777/uti.2019.14.2.33
32. Liu Z, Liang Q, Ren Y, Guo C, Ge X, Wang L, et al. Immunosenescence: molecular mechanisms and diseases. Signal Transduct Target Ther. 2023; 8(1): 200. https://doi.org/10.1038/s41392-023-01451-2
33. Wang Y, Dong C, Han Y, Gu Z, Sun C. Immunosenescence, ageing and successful ageing. Front Immunol. 2022; 13: 942796. https://doi.org/10.3389/fimmu.2022.942796
34. Teissier T, Boulanger E, Cox LS. Interconnections between inflammageing and immunosenescence during ageing. Cells. 2022; 11(3): 359. https://doi.org/10.3390/cells11030359
35. Santoro A, Bientinesi E, Monti D. Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?. Ageing Res Rev. 2021; 71: 101422. https://doi.org/10.1016/j.arr.2021.101422
36. Randhawa SS, Varghese D. Geriatric evaluation and treatment of age-related cognitive decline. Treasure Island (FL): StatPearls Publishing; 2025.
37. Scharp D, Harkins SE, Topaz M. Comorbidities of community-dwelling older adults with urinary incontinence: a scoping review. Geriatr Nurs. 2023; 53: 280-294. https://doi.org/10.1016/j.gerinurse.2023.08.005
38. Rodriguez-Mañas L. Urinary tract infections in the elderly: a review of disease characteristics and current treatment options. Drugs Context. 2020; 9: 2020-4-13. https://doi.org/10.7573/dic.2020-4-13
39. Czajkowski K, Broś-Konopielko M, Teliga-Czajkowska J. Urinary tract infection in women. Prz Menopauzalny. 2021; 20(1): 40-47. https://doi.org/10.5114/pm.2021.105382
40. Christmas MM, Iyer S, Daisy C, Maristany S, Letko J, Hickey M. Menopause hormone therapy and urinary symptoms: a systematic review. Menopause. 2023; 30(6): 672-685. https://doi.org/10.1097/GME.0000000000002187
41. Anger J, Lee U, Ackerman AL, Chou R, Chughtai B, Clemens JQ, et al. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline. J Urol. 2019; 202(2): 282-289. https://doi.org/10.1097/JU.0000000000000296
42. Choi JB, Min SK. Complicated urinary tract infection in patients with benign prostatic hyperplasia. J Infect Chemother. 2021; 27(9): 1284-1287. https://doi.org/10.1016/j.jiac.2021.06.006
43. Miernik A, Gratzke C. Current treatment for benign prostatic hyperplasia. Dtsch Arztebl Int. 2020; 117(49): 843-854. https://doi.org/10.3238/arztebl.2020.0843
44. Bientinesi R, Gandi C, Vaccarella L, Sacco E. Lifestyle in urology: benign diseases. Urologia. 2021; 88(3): 163-174. https://doi.org/10.1177/0391560321994386
45. Plochocki A, King B. Medical treatment of benign prostatic hyperplasia. Urol Clin North Am. 2022; 49(2): 231-238. https://doi.org/10.1016/j.ucl.2021.12.003
46. LeRoith D, Biessels GJ, Braithwaite SS, Casanueva FF, Draznin B, Halter JB, et al. Treatment of diabetes in older adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2019; 104(5): 1520-1574. https://doi.org/10.1210/jc.2019-00198
47. Hryniewicz W, Holecki M. [Recommendations for diagnosis, treatment, and prevention of urinary tract infections in adults] [Internet]. Warszawa: Narodowy Instytut Leków; 2015 [access May 2025]. Available from: https://antybiotyki.edu.pl (in Polish).
48. Mnif MF, Kamoun M, Kacem FH, Bouaziz Z, Charfi N, Mnif F, et al. Complicated urinary tract infections associated with diabetes mellitus: pathogenesis, diagnosis and management. Indian J Endocrinol Metab. 2013; 17(3): 442-445. https://doi.org/10.4103/2230-8210.111637
49. Agochukwu-Mmonu N, Pop-Busui R, Wessells H, Sarma AV. Autonomic neuropathy and urologic complications in diabetes. Auton Neurosci. 2020; 229: 102736. https://doi.org/10.1016/j.autneu.2020.102736
50. Yourman LC, Kent TJ, Israni JS, Ko KJ, Lesser A. Association of dementia diagnosis with urinary tract infection in the emergency department. J Am Coll Emerg Physicians Open. 2020; 1(6): 1291-1296. https://doi.org/10.1002/emp2.12268
51. McKinnell JA, Miller LG, Singh RD, Gussin G, Kleinman K, Mendez J, et al. High prevalence of multidrug-resistant organism colonization in 28 nursing homes: an “iceberg effect”. J Am Med Dir Assoc. 2020; 21(12): 1937-1943.e2. https://doi.org/10.1016/j.jamda.2020.04.007
52. Farrington N, Murphy C. Bladder management in palliative care. In: Ferrell BR, Paice JA, editors. Oxford textbook of palliative nursing. Oxford: Oxford University Press; 2016. p. 230-237. https://doi.org/10.1093/med/9780190862374.003.0017
53. Patel PK, Advani SD, Kofman AD, Lo E, Maragakis LL, Pegues DA, et al. Strategies to prevent catheter-associated urinary tract infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol. 2023; 44(8): 1209-1231. https://doi.org/10.1017/ice.2023.137
54. Rajaramon S, Shanmugam K, Dandela R, Solomon AP. Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review. Front Cell Infect Microbiol. 2023; 13: 1134433. https://doi.org/10.3389/fcimb.2023.1134433
55. Hariati H, Suza DE, Tarigan R. Risk factors analysis for catheter-associated urinary tract infection in Medan, Indonesia. Open Access Maced J Med Sci. 2019; 7(19): 3189-3194. https://doi.org/10.3889/oamjms.2019.798
56. Rotjanapan P, Dosa D, Thomas KS. Potentially inappropriate treatment of urinary tract infections in two Rhode Island nursing homes. Arch Intern Med. 2011; 171(5): 438-443. https://doi.org/10.1001/archinternmed.2011.13
57. D’Agata E, Loeb MB, Mitchell SL. Challenges in assessing nursing home residents with advanced dementia for suspected urinary tract infections. J Am Geriatr Soc. 2013; 61(1): 62-66. https://doi.org/10.1111/jgs.12070
58. Lo E, Nicolle LE, Coffin SE, Gould C, Maragakis LL, Meddings J, et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014; 35(5): 464-479. https://doi.org/10.1086/675718
59. Geerlings SE, Beerepoot MA, Prins JM. Prevention of recurrent urinary tract infections in women: antimicrobial and nonantimicrobial strategies. Infect Dis Clin North Am. 2014; 28(1): 135-147. https://doi.org/10.1016/j.idc.2013.10.001
60. European Association of Urology. EAU Guidelines. Presented at the EAU Annual Congress, Milan 2023. Arnhem: EAU Guidelines Office; 2023.
61. Nickel JC, Doiron RC. An effective sublingual vaccine, MV140, safely reduces risk of recurrent urinary tract infection in women. Pathogens. 2023; 12(3): 359. https://doi.org/10.3390/pathogens12030359
62. Cortes-Penfield NW, Trautner BW, Jump RLP. Urinary tract infection and asymptomatic bacteriuria in older adults. Infect Dis Clin North Am. 2017; 31(4): 673-688. https://doi.org/10.1016/j.idc.2017.07.002
Copyright: © 2025 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

© 2025 Termedia Sp. z o.o.
Developed by Bentus.